Atlas Trials

An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma

Clinical trial NCT07080437 · RECRUITING

Trial details

NCT number
NCT07080437
Sponsor
Three Gorges Hospital of Chongqing University
Status
RECRUITING
Study type
OBSERVATIONAL
Esophageal Squamous Cell Carcinoma (ESCC)
Start date
2021-03-01
Primary completion
2026-08-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.